Veradermics announced positive topline data from its Phase 2 study of VDPHL01 for mild-to-moderate female pattern hair loss. The company issued a press release and held a conference call and webcast on July 15, 2026.
View Full Filing (SEC EDGAR)Veradermics INC
+$1.6B
Net Activity
Institutions Holding
80
Popularity Rank
#4957
Avg Weight
0.64%
Total Value
$1.6B
Ownership Trend
80 institutions currently hold MANE, with 76 net buyers and 0 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Significantly Increased
Based on recent trading activity
Net Selling Institutions
0
Net Buying Institutions
76
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$1.6B
Total Buy Value
$0.0
Total Sell Value
76
Net Buyers
0
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
FAQ
Who are the top institutional investors holding VERADERMICS INC (MANE)?
What is the overall institutional sentiment toward MANE recently?
Which institutions have been selling or reducing their MANE positions?
Are there any notable investors adding MANE to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter